世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Precision Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
The global precision medicine market is set to witness significant transformation, with projections estimating its value to rise from US$35.9 Bn in 2025 to US$76.0 Bn by 2032. This impressive expan... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global precision medicine market is set to witness significant transformation, with projections estimating its value to rise from US$35.9 Bn in 2025 to US$76.0 Bn by 2032. This impressive expansion corresponds to a steady compound annual growth rate (CAGR) of 11.29% during the forecast period. Precision medicine, also known as personalized medicine, is redefining the healthcare Analysis by offering customized treatments based on an individual’s genetic, environmental, and lifestyle factors.Market Insights Precision medicine represents a paradigm shift from the traditional “one-size-fits-all” approach in medical treatment. At its core, the field leverages advanced diagnostics, genomic sequencing, targeted therapeutics, and AI-driven analytics to tailor treatments for individual patients. The market has seen considerable uptake in oncology, but its application is rapidly expanding into cardiology, neurology, rare diseases, and infectious diseases. Growing awareness about the benefits of personalized healthcare, along with increased accessibility to genetic testing, is driving this trend further. Stakeholders across pharmaceuticals, biotechnology, diagnostics, and healthcare IT are increasingly collaborating to drive innovation and deliver more effective solutions to patients. Drivers One of the primary drivers of the precision medicine market is the rapid advancement in genomic technologies. The evolution of next-generation sequencing (NGS) has significantly reduced the time and cost associated with decoding the human genome. This development enables healthcare professionals to identify disease-causing mutations and biomarkers with higher accuracy, leading to more effective and targeted treatments. Furthermore, a shift in healthcare focus toward the management of rare diseases is accelerating market momentum. The growing prevalence of rare genetic disorders, coupled with the development of orphan drugs and regulatory support, is encouraging innovation in molecular diagnostics and gene therapy. Additionally, increasing R&D investments, patient advocacy, and public-private partnerships are contributing to the rapid commercialization of personalized therapeutic solutions across major markets. Business Opportunity Emerging opportunities for market players include the integration of multi-omics data and the deployment of AI-based tools in predictive analytics and diagnostics. By combining genomic, proteomic, and metabolomic data, providers can gain a comprehensive understanding of disease mechanisms, leading to more accurate treatment planning. Expanding the use of precision medicine in pediatric care and chronic disease management also presents a lucrative avenue. Children with rare genetic conditions and pediatric cancers can benefit from personalized treatments, with significant potential to improve long-term health outcomes. Moreover, the growing focus on patient-centered care is pushing companies to develop digital health platforms that enhance transparency, empower patients, and support clinical decision-making. Region Analysis North America remains the frontrunner in the global precision medicine market due to its robust healthcare infrastructure, advanced research capabilities, and early adoption of new technologies. The presence of key pharmaceutical and biotech firms in the region fosters continuous innovation in diagnostics, therapeutics, and AI-enabled healthcare tools. Europe follows closely, benefiting from strong government funding for genomics research and high patient awareness. The Asia Pacific region is emerging as a key growth hub, driven by rising healthcare expenditure, improving medical infrastructure, and increasing focus on personalized healthcare in countries like China, India, and Japan. Key Players Several global pharmaceutical and biotechnology companies are actively contributing to the growth of the precision medicine market. Key players include: • Pfizer Inc. • Bristol Myers Squibb • Hoffmann-La Roche Ltd. • Novartis AG • AstraZeneca • Merck KGaA • Eli Lilly and Company • GlaxoSmithKline plc • Sanofi • Johnson & Johnson • Amgen, Inc. • Gilead Sciences, Inc. • AbbVie Inc. These companies are investing in advanced diagnostics, gene editing technologies, and strategic collaborations to expand their precision medicine portfolios and improve patient outcomes. Segmentation The global precision medicine market is segmented as follows: By Type • Inhibitor Drugs • Monoclonal Antibodies • Cell & Gene Therapy • Antiviral & Anti-retroviral Drugs • Other Therapeutic Products By Indication • Oncology • Rare Diseases • Infectious Diseases • Hematological Disorders • Other Indications By End User • Hospitals and Clinics • Home Care Settings By Region • North America • Europe • Asia Pacific • Latin America • Middle East • Africa Table of Contents1. Executive Summary1.1. Global Precision Medicine Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value, 2025 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. Porter’s Five Forces Analysis 2.5. COVID-19 Impact Analysis 2.5.1. Supply 2.5.2. Demand 2.6. Impact of Ukraine-Russia Conflict 2.7. Economic Overview 2.7.1. World Economic Projections 2.8. PESTLE Analysis 3. Global Precision Medicine Market Outlook, 2019-2032 3.1. Global Precision Medicine Market Outlook, by Technology, Value (US$ Bn), 2019-2032 3.1.1. Key Highlights 3.1.1.1. Next Generation Sequencing 3.1.1.2. Bioinformatics 3.1.1.3. Drug Discovery Technologies 3.2. Global Precision Medicine Market Outlook, by Application, Value (US$ Bn), 2019-2032 3.2.1. Key Highlights 3.2.1.1. Oncology 3.2.1.2. Immunology 3.2.1.3. Neurology 3.2.1.4. Cardiology 3.2.1.5. Infectious disease 3.2.1.6. Others 3.3. Global Precision Medicine Market Outlook, by Region, Value (US$ Bn), 2019-2032 3.3.1. Key Highlights 3.3.1.1. North America 3.3.1.2. Europe 3.3.1.3. Asia Pacific 3.3.1.4. Latin America 3.3.1.5. Middle East & Africa 4. North America Precision Medicine Market Outlook, 2019-2032 4.1. North America Precision Medicine Market Outlook, by Technology, Value (US$ Bn), 2019-2032 4.1.1. Key Highlights 4.1.1.1. Next Generation Sequencing 4.1.1.2. Bioinformatics 4.1.1.3. Drug Discovery Technologies 4.2. North America Precision Medicine Market Outlook, by Application, Value (US$ Bn), 2019-2032 4.2.1. Key Highlights 4.2.1.1. Oncology 4.2.1.2. Immunology 4.2.1.3. Neurology 4.2.1.4. Cardiology 4.2.1.5. Infectious disease 4.2.1.6. Others 4.2.2. BPS Analysis/Market Attractiveness Analysis 4.3. North America Precision Medicine Market Outlook, by Country, Value (US$ Bn), 2019-2032 4.3.1. Key Highlights 4.3.1.1. U.S. Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 4.3.1.2. U.S. Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 4.3.1.3. Canada Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 4.3.1.4. Canada Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 4.3.2. BPS Analysis/Market Attractiveness Analysis 5. Europe Precision Medicine Market Outlook, 2019-2032 5.1. Europe Precision Medicine Market Outlook, by Technology, Value (US$ Bn), 2019-2032 5.1.1. Key Highlights 5.1.1.1. Next Generation Sequencing 5.1.1.2. Bioinformatics 5.1.1.3. Drug Discovery Technologies 5.2. Europe Precision Medicine Market Outlook, by Application, Value (US$ Bn), 2019-2032 5.2.1. Key Highlights 5.2.1.1. Oncology 5.2.1.2. Immunology 5.2.1.3. Neurology 5.2.1.4. Cardiology 5.2.1.5. Infectious disease 5.2.1.6. Others 5.2.2. BPS Analysis/Market Attractiveness Analysis 5.3. Europe Precision Medicine Market Outlook, by Country, Value (US$ Bn), 2019-2032 5.3.1. Key Highlights 5.3.1.1. Germany Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 5.3.1.2. Germany Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 5.3.1.3. U.K. Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 5.3.1.4. U.K. Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 5.3.1.5. France Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 5.3.1.6. France Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 5.3.1.7. Italy Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 5.3.1.8. Italy Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 5.3.1.9. Turkey Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 5.3.1.10. Turkey Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 5.3.1.11. Russia Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 5.3.1.12. Russia Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 5.3.1.13. Rest of Europe Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 5.3.1.14. Rest of Europe Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 5.3.2. BPS Analysis/Market Attractiveness Analysis 6. Asia Pacific Precision Medicine Market Outlook, 2019-2032 6.1. Asia Pacific Precision Medicine Market Outlook, by Technology, Value (US$ Bn), 2019-2032 6.1.1. Key Highlights 6.1.1.1. Next Generation Sequencing 6.1.1.2. Bioinformatics 6.1.1.3. Drug Discovery Technologies 6.2. Asia Pacific Precision Medicine Market Outlook, by Application, Value (US$ Bn), 2019-2032 6.2.1. Key Highlights 6.2.1.1. Oncology 6.2.1.2. Immunology 6.2.1.3. Neurology 6.2.1.4. Cardiology 6.2.1.5. Infectious disease 6.2.1.6. Others 6.2.2. Others BPS Analysis/Market Attractiveness Analysis 6.3. Asia Pacific Precision Medicine Market Outlook, by Country, Value (US$ Bn), 2019-2032 6.3.1. Key Highlights 6.3.1.1. China Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 6.3.1.2. China Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 6.3.1.3. Japan Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 6.3.1.4. Japan Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 6.3.1.5. South Korea Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 6.3.1.6. South Korea Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 6.3.1.7. India Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 6.3.1.8. India Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 6.3.1.9. Southeast Asia Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 6.3.1.10. Southeast Asia Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 6.3.1.11. Rest of Asia Pacific Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 6.3.1.12. Rest of Asia Pacific Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 6.3.2. BPS Analysis/Market Attractiveness Analysis 7. Latin America Precision Medicine Market Outlook, 2019-2032 7.1. Latin America Precision Medicine Market Outlook, by Technology, Value (US$ Bn), 2019-2032 7.1.1. Key Highlights 7.1.1.1. Next Generation Sequencing 7.1.1.2. Bioinformatics 7.1.1.3. Drug Discovery Technologies 7.2. Latin America Precision Medicine Market Outlook, by Application, Value (US$ Bn), 2019-2032 7.2.1.1. Oncology 7.2.1.2. Immunology 7.2.1.3. Neurology 7.2.1.4. Cardiology 7.2.1.5. Infectious disease 7.2.1.6. Others 7.2.2. BPS Analysis/Market Attractiveness Analysis 7.3. Latin America Precision Medicine Market Outlook, by Country, Value (US$ Bn), 2019-2032 7.3.1. Key Highlights 7.3.1.1. Brazil Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 7.3.1.2. Brazil Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 7.3.1.3. Mexico Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 7.3.1.4. Mexico Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 7.3.1.5. Argentina Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 7.3.1.6. Argentina Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 7.3.1.7. Rest of Latin America Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 7.3.1.8. Rest of Latin America Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 7.3.2. BPS Analysis/Market Attractiveness Analysis 8. Middle East & Africa Precision Medicine Market Outlook, 2019-2032 8.1. Middle East & Africa Precision Medicine Market Outlook, by Technology, Value (US$ Bn), 2019-2032 8.1.1. Key Highlights 8.1.1.1. Next Generation Sequencing 8.1.1.2. Bioinformatics 8.1.1.3. Drug Discovery Technologies 8.2. Middle East & Africa Precision Medicine Market Outlook, by Application, Value (US$ Bn), 2019-2032 8.2.1. Key Highlights 8.2.1.1. Oncology 8.2.1.2. Immunology 8.2.1.3. Neurology 8.2.1.4. Cardiology 8.2.1.5. Infectious disease 8.2.1.6. Others 8.2.2. BPS Analysis/Market Attractiveness Analysis 8.3. Middle East & Africa Precision Medicine Market Outlook, by Country, Value (US$ Bn), 2019-2032 8.3.1. Key Highlights 8.3.1.1. GCC Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 8.3.1.2. GCC Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 8.3.1.3. South Africa Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 8.3.1.4. South Africa Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 8.3.1.5. Egypt Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 8.3.1.6. Egypt Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 8.3.1.7. Nigeria Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 8.3.1.8. Nigeria Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 8.3.1.9. Rest of Middle East & Africa Precision Medicine Market by Technology, Value (US$ Bn), 2019-2032 8.3.1.10. Rest of Middle East & Africa Precision Medicine Market by Application, Value (US$ Bn), 2019-2032 8.3.2. BPS Analysis/Market Attractiveness Analysis 9. Competitive Landscape 9.1. Manufacturer vs by Application Heatmap 9.2. Company Market Share Analysis, 2025 9.3. Competitive Dashboard 9.4. Company Profiles 9.4.1. F. Hoffmann-La Roche AG 9.4.1.1. Company Overview 9.4.1.2. Product Portfolio 9.4.1.3. Financial Overview 9.4.1.4. Business Strategies and Development 9.4.2. Illumina, Inc. 9.4.2.1. Company Overview 9.4.2.2. Product Portfolio 9.4.2.3. Financial Overview 9.4.2.4. Business Strategies and Development 9.4.3. Thermo Fisher Scientific Inc. 9.4.3.1. Company Overview 9.4.3.2. Product Portfolio 9.4.3.3. Financial Overview 9.4.3.4. Business Strategies and Development 9.4.4. QIAGEN 9.4.4.1. Company Overview 9.4.4.2. Product Portfolio 9.4.4.3. Financial Overview 9.4.4.4. Business Strategies and Development 9.4.5. Quest Diagnostics 9.4.5.1. Company Overview 9.4.5.2. Product Portfolio 9.4.5.3. Financial Overview 9.4.5.4. Business Strategies and Development 9.4.6. Lboratory Corporation of America Holdings 9.4.6.1. Company Overview 9.4.6.2. Product Portfolio 9.4.6.3. Financial Overview 9.4.6.4. Business Strategies and Development 9.4.7. Novartis AG 9.4.7.1. Company Overview 9.4.7.2. Product Portfolio 9.4.7.3. Financial Overview 9.4.7.4. Business Strategies and Development 9.4.8. AstraZeneca 9.4.8.1. Company Overview 9.4.8.2. Product Portfolio 9.4.8.3. Financial Overview 9.4.8.4. Business Strategies and Development 9.4.9. Bristol-Myers Squibb 9.4.9.1. Company Overview 9.4.9.2. Product Portfolio 9.4.9.3. Financial Overview 9.4.9.4. Business Strategies and Development 9.4.10. Eli Lilly And Company 9.4.10.1. Company Overview 9.4.10.2. Product Portfolio 9.4.10.3. Financial Overview 9.4.10.4. Business Strategies and Development 10. Appendix 10.1. Research Methodology 10.2. Report Assumptions 10.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療IT）の最新刊レポート
Fairfield Market Research社の ヘルスケアIT分野 での最新刊レポート
本レポートと同じKEY WORD（medicine）の最新刊レポート
よくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
